Company / Profit Margin
IMMUCELL CORP /DE/ Profit Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-8.1%
FY2025
5-year range
-33.1% / 11.9%
FY2021-FY2025
Trend
+75.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 3 years of decline, reaching -8.1%.
Based on SEC 10-K filings.
-8.1% in FY2025 with a 10-year CAGR of -10.1%.
Improved from -13.4% to -8.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -10.1pp
Key checks
Key Insights
- In FY2025, profit margin increased 75.4% year-over-year.
- Peak profit margin was recorded in FY2016.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.1% | +75.4% |
| FY2024 | -33.1% | -146.1% |
| FY2023 | -13.4% | -352.0% |
| FY2017 | 5.3% | -55.1% |
| FY2016 | 11.9% | +508.2% |
| FY2015 | 1.9% | +17.5% |
| FY2014 | 1.7% | +120.7% |
| FY2013 | -8.0% | +8.7% |
| FY2012 | -8.8% | -82.7% |
| FY2011 | -4.8% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026